title: [Using Necrosis Biomarkers for the Early Diagnosis of Myocardial Infarction in Modern Conditions].
abstract: The implimentation of reperfusion treatment of acute coronary syndrome marked the problem of timely allocation of patients with high thrombotic risk. One of the key ways to do this is to use modern biomarkers. The review deals with the peculiarities of using for this purpose the definition of troponin, myoglobin and phosphokinase.
authors.affiliation: 1City Clinical Hospital 51, Moscow, Russia; 2Central State Medical Academy, President Management Department RF, Moscow, Russia; 3Federal Research Clinical Center for specialized types of health care and medical technologies, Moscow, Russia.
authors.forename: V A
authors.initials: VA
authors.lastname: Braznik
authors.affiliation: 1City Clinical Hospital 51, Moscow, Russia; 2Central State Medical Academy, President Management Department RF, Moscow, Russia; 3Federal Research Clinical Center for specialized types of health care and medical technologies, Moscow, Russia.
authors.forename: D A
authors.initials: DA
authors.lastname: Zateyshchikov
mesh_terms: D015415:Biomarkers / Q000097:blood*; D003402:Creatine Kinase / Q000097:blood; D042241:Early Diagnosis; D006801:Humans; D009203:Myocardial Infarction / Q000097:blood / Q000175:diagnosis*; D009211:Myoglobin / Q000097:blood; D009336:Necrosis / Q000378:metabolism; D014336:Troponin / Q000097:blood
chemical_list: D015415:Biomarkers; D009211:Myoglobin; D014336:Troponin; D003402:Creatine Kinase